Latest filing published 02 Jul 2012 for UROLOGIX INC, €121k.
Insider track record
No signal scores available.
Closed purchases
Based on 15 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -56.6%Entry US$0.83 · Close at T+365 US$0.36
- +90.5%Entry US$0.63 · Close at T+365 US$1.20
- +30.8%Entry US$0.78 · Close at T+365 US$1.02
- +30.8%Entry US$0.78 · Close at T+365 US$1.02
- -4.3%Entry US$0.94 · Close at T+365 US$0.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Stryker Warren Jr.: trading record in brief
Stryker Warren Jr. appears in our data through filings on Urologix Inc shares, published by SEC (Form 4). We count 19 filings; the first trade dates from 24 June 2008 and the latest from 29 June 2012.
Every open-market trade on record is a purchase: 15 purchases worth €155k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant and 3 option exercises. 2012 to date brings 1 purchase and no sales.
Half of the purchases are above €2,215 and half below. For 15 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 40% of cases, with a median move of -10.5%. This is a record of the past, not a forecast.
The record was last updated on 2 July 2012 with an open-market purchase (€121k) in Urologix Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Stryker Warren Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 200,000 shares@ US$0.75Common StockSEC:0001362118-12-000092:0Canonical exit: 27 Sept 2012 (T+90)
- 10,833 shares@ US$0.91Common StockSEC:0001362118-12-000052:0
- 49,997 shares@ US$1.30Common StockSEC:0001362118-11-000077:0
- 16,250 shares@ US$0.91Common StockSEC:0001362118-11-000077:1
- 5,200 shares@ US$0.59Common StockSEC:0001362118-11-000004:0Canonical exit: 28 Apr 2011 (T+90)
- 3,951 shares@ US$0.76Common StockSEC:0001362118-10-000066:0Canonical exit: 16 Feb 2011 (T+90)
- 2,000 shares@ US$0.78Common StockSEC:0001362118-10-000066:1Canonical exit: 16 Feb 2011 (T+90)
- 200 shares@ US$0.79Common StockSEC:0001362118-10-000066:2Canonical exit: 16 Feb 2011 (T+90)
- 3,527 shares@ US$0.80Common StockSEC:0001362118-10-000066:3Canonical exit: 16 Feb 2011 (T+90)
- 322 shares@ US$0.76Common StockSEC:0001362118-10-000065:0Canonical exit: 15 Feb 2011 (T+90)
- 5,000 shares@ US$0.79Common StockSEC:0001362118-10-000042:0Canonical exit: 25 Nov 2010 (T+90)
- 5,000 shares@ US$1.10Common StockSEC:0001262014-09-000020:0Canonical exit: 4 Mar 2010 (T+90)
- 11,900 shares@ US$1.14Common StockSEC:0001262014-09-000020:1Canonical exit: 7 Mar 2010 (T+90)
- 3,100 shares@ US$1.12Common StockSEC:0001362118-09-000050:0Canonical exit: 3 Mar 2010 (T+90)
- 1,870 shares@ US$1.20Common StockSEC:0001362118-09-000038:0Canonical exit: 30 Nov 2009 (T+90)
- 1,635 shares@ US$1.20Common StockSEC:0001362118-09-000035:0Canonical exit: 26 Nov 2009 (T+90)
- 1,495 shares@ US$1.00Common StockSEC:0001262014-09-000008:0Canonical exit: 25 Aug 2009 (T+90)
- 5,000 shares@ US$1.00Common StockSEC:0001362118-09-000018:0Canonical exit: 13 Aug 2009 (T+90)
- 80,000 shares0Common StockSEC:0001262014-08-000036:0
19 of 19 declarations
